Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-542 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2019-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_941275647bb81a1a109e7c7e1cf1a33a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad75aade467dc934a9f33be3f016b081 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_321dba9d736f4dc67e2e499def27fe04 |
publicationDate |
2019-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
TW-I672315-B |
titleOfInvention |
Deuterated insulin compound |
abstract |
The compounds described herein are related to the treatment of diabetes and / or hyperglycemia. More specifically, the compounds described are related to hypoglycemic insulin compounds that reduce blood glucose, pharmaceutical compositions containing these compounds, therapeutic use of these compounds, and intermediate compounds for the preparation of such halogenated insulin compounds. |
priorityDate |
2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |